2010

List of Whitehall II publications by Whitehall II researchers, ordered alphabetically by first author.

Please see below Consortium papers where Whitehall II data were used.

• Overall diet history and reversibility of the metabolic syndrome over 5 years: the Whitehall II prospective cohort study. Akbaraly TN, Singh-Manoux A, Tabak AG, Jokela M, Virtanen M, Ferrie JE, Marmot MG, Shipley MJ, Kivimaki M. Diabetes Care. 2010 Nov;33(11):2339-41 (PMID: 20671094)
• Metabolic syndrome over 10 years and cognitive functioning in late midlife: the Whitehall II study. Akbaraly TN, Kivimaki M, Shipley MJ, Tabak AG, Jokela M, Virtanen M, Marmot MG, Ferrie JE, Singh-Manoux A.  Diabetes Care. 2010 Jan;33(1):84-9.
• Bored to death. Britton A., Shipley M.  Int J Epidemiology 2010 ;39:370-1
• How does variability in alcohol consumption over time affect the relationship with mortality and coronary heart disease? Britton A, Marmot M, Shipley M. Addiction. 2010;105:639-45
• Authors' response to commentary. Britton A, Marmot M, Shipley M.  Addiction 2010;105:647-8
• Do the Joint British Society (JBS2) guidelines on prevention of cardiovascular disease with respect to plasma glucose improve risk stratification in the general population? Brunner EJ, Shipley MJ, Marmot MG, Kivimäki M, Witte DR.  Prospective cohort study. Diabetic Medicine 2010;27,550-555.
• Height loss and future coronary heart disease in London: the Whitehall II study. Kivimaki M.  J Epidemiol Community Health. 2010 Aug 30.
• Walking pace, leisure time physical activity, and resting heart rate in relation to disease-specific mortality in London: 40 years follow-up of the original Whitehall study. An update of our work with professor Jerry N. Morris (1910-2009). Batty D, Shipley M, Kivimaki M, Marmot MG, Davey Smith G.  Ann Epidemiol. 2010 Sep;20(9):661-9.
• Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study. Carstensen M, Herder C, Brunner EJ, Strassburger K, Tabak AG, Roden M, Witte DR. Eur J Endocrinol. 2010 May;162(5):913-7.
• Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study. Carstensen M, Herder C, Kivimäki M, Jokela M, Roden M, Shipley MJ, Witte DR, Brunner EJ, Tabák AG.  Diabetes. 2010 May;59(5):1222-7.
• PLA2G7 Genotype, Lipoprotein-Associated Phospholipase A2 Activity, and Coronary Heart Disease Risk in 10 494 Cases and 15 624 Controls of European Ancestry. Casas JP, [...], Kumari M, Brunner EJ, Kivimaki M, Marmot MG, et al.  Circulation. 2010 Jun 1;121(21):2284-93.
• The effect of short sleep duration on coronary heart disease risk is greatest among those with sleep disturbance: a prospective study from the Whitehall II cohort. Chandola T, Ferrie JE, Perski A, Akbaraly T, Marmot MG.  Sleep. 2010 Jun 1;33(6):739-44.
• Psychophysiological biomarkers of workplace stressors. Chandola T, Heraclides A, Kumari M.  Neurosci Biobehav Rev. 2010 Sep;35(1):51-7.
• Moving to an HbA1c based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Christensen D.L., Witte D.R., Kaduka L., Jørgensen M., Borch-Johnsen K., Mohan V., Shaw D., Tabák A.G., Vistisen D. Diabetes Care. 2010 Mar;33(3):580-2.
• Dietary fiber with colorectal cancer risk: a nested case control study using food diaries. Dahm CC, Keogh RH, Spencer EA, Greenwood DC, Key TJ, Fentiman IS Shipley MJ, Brunner EJ, Cade JE, Burley VJ, Mishra G, Stephen AM, Kuh D, White IR, Luben R, Lentjes MAH, Khaw KT, Rodwell (Bingham) SA.  J Natl Cancer Inst 2010:102:1-13
•  Novel genetic loci implicated in fasting glucose homeostasis 3 and their impact on type 2 diabetes risk. Dupuis, J., Langenberg, C., Prokopenko, I., et al for the MAGIC investigators (>100 authors). Nature Genetics 2010;42, 142-148.
• Organisational justice and cognitive function in middle-aged employees: the Whitehall II study. Elovainio M, Singh-Manoux A, Ferrie JE, Shipley M, Gimeno D, De Vogli R, Vahtera J, Virtanen M, Jokela M, Marmot MG, Kivimäki M.  J Epidemiol Community Health. 2010 Nov 17.
• Organisational justice and markers of inflammation: the Whitehall II study. Elovainio M, Ferrie JE, Singh-Manoux A, Gimeno D, De Vogli R, Shipley M, Vahtera J, Brunner E, Marmot MG, Kivimäki M.  Occup Environ Med. 2010 Feb;67(2):78-83.
• Sleep and Death. Chapter 4. Sleep, Health and Society: From Aetiology to Public Health. Ferrie JE, Kivimäki M, Shipley M.  Ed. Cappuccio FP, Miller M and Lockley S. Oxford University Press September 2010
• Association between change in body composition and change in inflammatory markers: an 11-year follow-up in the Whitehall II Study. Fransson EI, Batty GD, Tabák AG, Brunner EJ, Kumari M, Shipley MJ, Singh-Manoux A, Kivimäki M.  J Clin Endocrinol Metab. 2010 Dec;95(12):5370-4.
• Justice at work and metabolic syndrome: the Whitehall II study. Gimeno D, Tabák AG, Ferrie JE, Shipley MJ, De Vogli R, Elovainio M, Vahtera J, Marmot MG, Kivimäki M.  Occup Environ Med. 2010 Apr;67(4):256-62.
• Walking speed and subclinical atherosclerosis in healthy older adults: the Whitehall II study. Hamer M, Kivimaki M, Lahiri A, Yerramasu A, Deanfield JE, Marmot MG, Steptoe A.Heart. 2010 Mar;96(5):380-4.
• Persistent cognitive depressive symptoms are associated with coronary artery calcification. Hamer, M., Kivimäki, M., Lahiri, A., Marmot, M. G., Steptoe, A.  Atherosclerosis, 2010;210, 209-213.
• Social mobility and social accumulation across the life course in relation to adult overweight and obesity: the Whitehall II study. Heraclides A, Brunner E. J Epidemiol Community Health. 2010 Aug;64(8):714-9.
• Translating genomics into improved healthcare. Hingorani AD, Shah T, Kumari M, Sofat R, Smeeth L.  BMJ. 2010 Nov 5;341.
• Do pre-employment influences explain the association between psychosocial factors at work and coronary heart disease? Hintsa T, Shipley MJ, Gimeno D, Elovainio M, Chandola T, Jokela M, Keltikangas-Järvinen L, Vahtera J, Marmot MG, Kivimäki M.  The Whitehall II study. Occup Environ Med. 2010 May;67(5):330-4.
• The association of cognitive performance with mental health and physical functioning strengthens with age: the Whitehall II cohort study. Jokela M, Singh-Manoux A, Ferrie JE, Gimeno D, Akbaraly TN, Shipley MJ, Head J, Elovainio M, Marmot MG, Kivimäki M.  Psychol Med. 2010 May;40(5):837-45.
• Natural course of recurrent psychological distress in adulthood. Jokela M, Singh-Manoux A, Shipley MJ, Ferrie JE, Gimeno D, Akbaraly TN, Head J, Elovainio M, Marmot MG, Kivimäki M.  J of Affect Disord 2010.
• From midlife to early old age: health trajectories associated with retirement. Jokela M, Ferrie JE, Gimeno D, Chandola T, Shipley MJ, Head J, Vahtera J, Westerlund H, Marmot MG, Kivimäki M.  Epidemiology 2010, 21, 284-290
• Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men. Ken-Dror, G., Drenos, F., Humphries, S. E., Talmud, P. J., Hingorani, A. D., Kivimäki, M., Kumari, M., Bauer, K. A., Morrissey, J. H., Ireland, H. A.  Journal of Thrombosis and Haemostasis, 2010; 8, 2394-2403.
• Incremental predictive value of using past blood pressure measurements in the Framingham hypertension risk equation: the Whitehall II study. Kivimäki M, Tabak A, Batty GD, Ferrie JE, Nabi H, Marmot MG, Witte DR, Singh-Manoux A, Shipley MJ.  Hypertension 2010 Apr;55(4):1058-62
• Psychosocial Factors at Work: The Epidemiological Perspective. Chapter 11, Stress and Cardiovascular Disease. Kivimäki M, Singh-Manoux A, Batty GD, Virtanen M, Ferrie JE, Vahtera J. Ed. Hjemdahl P, Rosengren A, Steptoe A. Springer July 2010.
• Identifying patterns in cortisol secretion in an older population. Findings from the Whitehall II study. Kumari M, Badrick E, Sacker A, Kirschbaum C, Marmot M, Chandola T.  Psychoneuroendocrinology. 2010 Aug;35(7):1091-9.
• A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in the Whitehall II study. Kumari M, Chandola T, Brunner E, Kivimaki M.  J Clin Endocrinol Metab. 2010 Sep;95(9):4415-23.
• Measures of social position and cortisol secretion in an aging population: findings from the Whitehall II study. Kumari M, Badrick E, Chandola T, Adler NE, Epel E, Seeman T, Kirschbaum C, Marmot MG.  Psychosom Med. 2010 Jan;72(1):27-34.
• Economic difficulties and physical functioning among Finnish and British employees: the contribution of social and behavioural factors. Laaksonen E, Lallukka T, Lahelma E, Ferrie JE, Rahkonen O, Head J, Marmot M, Martikainen P. Eur.J.Pub.Health 2010 Jul 8.
• Social class differences in health behaviours among employees from Britain, Finland and Japan: The influence of psychosocial factors. Lahelma E, Lallukka T, Laaksonen M, Martikainen P, Rahkonen O, Chandola T, Head J, Marmot M, Kagamimori S, Tatsuse T, Sekine M.  Health Place 2010 Jan;16(1):61-70.
• Relationships between sleep duration and von Willebrand factor, factor VII, and fibrinogen: Whitehall II study. Miller MA, Kandala NB, Kumari M, Marmot MG, Cappuccio FP.  Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):2032-8.
• Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: the Whitehall II cohort study. Nabi H, Shipley MJ, Vahtera J, Hall M, Korkeila J, Marmot MG, Kivimäki M, Singh-Manoux A.  Heart. 2010 Oct;96(20):1645-50.
• Hostility and depressive mood: results from the Whitehall II prospective cohort study. Nabi H, Singh-Manoux A, Ferrie JE, Marmot MG, Melchior M, Kivimäki M.  Psychol Med. 2010 Mar;40(3):405-13.
• Alcohol intake and risk of colorectal cancer: results from the UK Dietary Cohort Consortium. Park JY, Dahm CC, Keogh RH, Mitrou PN, Cairns BJ, Greenwood DC, Spencer EA, Fentiman IS, Shipley MJ, Brunner EJ, Cade JE, Burley VJ, Mishra GD, Kuh D, Stephen AM, White IR, Luben RN, Mulligan AA, Khaw K-T, Rodwell SA.  Brit J Cancer 2010;103: 747-756.
• Why does lung function predict mortality? Results from the Whitehall II Cohort Study. Sabia S, Shipley M, Elbaz A, Marmot M, Kivimaki M, Kauffmann F, Singh-Manoux A. Am J Epidemiol. 2010 Dec 15;172(12):1415-23.
• Does cognition predict mortality in midlife? Results from the Whitehall II cohort study. Sabia S, Guéguen A, Marmot MG, Shipley MJ, Ankri J, Singh-Manoux A.  Neurobiol Aging. 2010 Apr;31(4):688-95. Epub 2008 Jun 9.
• Effect of Apolipoprotein E epsilon4 on the association between health behaviors and cognitive function in late midlife. Sabia S, Kivimaki M, Kumari M, Shipley MJ, Singh-Manoux A.  Mol Neurodegener. 2010 Jun 1;5(1):23.
• Work stress and health in Western European and post-communist countries: an East-West comparison study. Salavecz G, Chandola T, Pikhart H, Dragano N, Siegrist J, Jöckel KH, Erbel R, Pajak A, Malyutina S, Kubinova R, Marmot M, Bobak M, Kopp M.  J Epidemiol Community Health. 2010 Jan;64(1):57-62.
• Genetic variation in gastric inhibitory polypeptide receptor (GIPR) impacts the glucose and insulin responses to an oral glucose challenge. Saxena, R., […..],Kivimaki M, […..], Kumari M, […..], Marmot M, et al.,  Nature Genetics, 2010; 42, 142-148.
• Persistent depressive symptoms and cognitive function in late midlife: The Whitehall II study. Singh-Manoux A, Akbaraly TN, Marmot M, Melchior M, Ankri J, Sabia S, Ferrie JE. J Clin Psychiatry 2010; 71: 1379-85. 
• The importance of cognitive ageing for understanding dementia.  Singh-Manoux A, Kivimäki M. Age 2010; 32: 509-512.
• Socioeconomic position and mortality-Reply. Singh-Manoux A, Stringhini S. JAMA 2010; 204: 271.
• Commentary: Is it time to redefine Cognitive Epidemiology? Singh-Manoux A.  Int J Epidemiol 2010; 39:1369-71
• The relationship between plasma angiopoietinlike protein l4 levels, angioloietinlike protein 4 genotype and coronary heart disease risk. Smart-Halajko, M. C., Robciuc, M. R., Cooper, J. A., Jauhiainen, M., Kumari, M., Kivimäki, M., Khaw, K-T., Boekholdt, M., Wareham, N. J., Gaunt, T. R., Day, I. N. on behalf of BWHHS, Braund, P. S., Nelson, C. P., Hall, A. S., Samani, N. J. on behalf of the BHF-FHS, Humphries, S. E., Ehnholm, C., Talmud, P. J. (2010). Arteriosclerosis, Thrombosis and Vascular Biology, 30, 2217-2282.
• Genetic variation in complement factor H and risk of coronary heart disease: Eight new studies and a meta-analysis of around 48,000 individuals. Sofat, R., Casas, J. P., Kumari, M., Talmud, P. J., Ireland, H., Kivimäki, M., Marmot, M., Hughes, A. D., Thom, S., Ebrahim, S., Whittaker, J. C., Smeeth, L., Lawlor, D. A., Humphries, S. E., Hingorani, A. D. (2010).  Atherosclerosis, 121, 52-62.
• Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Sofat R, Hingorani AD, Smeeth L, Humphries SE, [...], Kumari M, Kivimaki M, Marmot M, et al.  Circulation. 2010 Jan 5;121(1):52-62.
• Socioeconomic status and subclinical coronary disease in the Whitehall II epidemiological study. Steptoe A, Hamer M, O'Donnell K, Venuraju S, Marmot MG, Lahiri A. PLoS One. 2010 Jan 25;5(1):e8874.
• Do different measures of early life socioeconomic circumstances predict adult mortality? Evidence from the British Whitehall II and French GAZEL studies.Stringhini S, Dugravot A, Kivimaki M, Shipley M, Zins M, Goldberg M, Ferrie JE, Singh-Manoux A.  J Epidemiol Community Health. 2010 Jul 30.
• Contribution of health behaviours to socioeconomic differences in mortality in the Whitehall II study. Stringhini S, Sabia S, Shipley M, Brunner E, Nabi H, Kivimaki M, Singh-Manoux A. JAMA 2010;303(12):1159-1166.
• Changes in C-reactive protein levels before type 2 diabetes and cardiovascular death: the Whitehall II study. Tabák AG, Kivimäki M, Brunner EJ, Lowe GD, Jokela M, Akbaraly TN, Singh-Manoux A, Ferrie JE, Witte DR.  Eur J Endocrinol. 2010 Jul;163(1):89-95.
• Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. Talmud PJ, Hingorani AD, Cooper JA, Marmot MG, Brunner EJ, Kumari M, Kivimäkin M, Humphries SE.  BMJ. 2010 Jan 14;340:b4838.
• Overtime work and incident coronary heart disease: the Whitehall II prospective cohort study. Virtanen M, Ferrie JE, Singh-Manoux A, Shipley MJ, Vahtera J, Marmot MG, Kivimäki M. . Eur Heart J. 2010 Jul;31(14):1737-44. Epub 2010 May 11.
• Work disability following major organisational change: the Whitehall II study. Virtanen M, Kivimäki M, Singh-Manoux A, Gimeno D, Shipley MJ, Vahtera J, Akbaraly TN, Marmot MG, Ferrie JE.  J Epidemiol Community Health. 2010 May;64(5):461-4.
• Performance of existing risk scores in screening for undiagnosed diabetes: An external validation study. Witte DR, Shipley MJ, Marmot MG, Brunner EJ. Diabetic Medicine, 2010;27:46-53

Consortium Papers

• Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables. CRP CHD genetics collaboration.  Statistics in Medicine (in press)
• Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J.  Lancet. 2010 May 8;375(9726):1634-9.

[top]